Bladder cancer does not always announce itself with dramatic pain or a sudden health crisis. In many people, the earliest bladder cancer symptoms look ordinary, brief, or easy to dismiss. A little ...

WHEN Grant Learmont began suffering with a stiff back and hips in January, he blamed it on “aches and pains” caused by his ...

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Get started with Staying Sharp. Follow this simple, flexible ...

Modern Advancements in Radiation Oncology: What Every Oncologist Should Know The causal link between smoking and bladder cancer (BC) development is well established but the long-term impact of tobacco ...

A combination of Merck’s Keytruda and Pfizer’s Padcev could offer a chemotherapy-free treatment alternative for patients with muscle-invasive bladder cancer, even those eligible for cisplatin ...

In 2023, the city of Boston sounded the alarm over a stark 23-year life expectancy gap between people who live in Roxbury compared to those in Back Bay. A broader examination of the issue now shows a ...

Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...

The gulf in life expectancy between Black Bostonians and all other races has doubled in the last decade, a new analysis finds. “ We cannot claim Boston as a beacon of health care while entire ...

Perioperative enfortumab vedotin plus pembrolizumab and surgery lead to significantly better outcomes among patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based ...

Protara Therapeutics has touted a 66% complete response (CR) rate for its cell therapy among certain bladder cancer patients as “impressive,” despite this rate halving at the 12-month mark. The New ...

Life expectancy after 65 reached 19.7 years. Retirees now need portfolios designed for 25-30 years not 15-18. Financial planners now recommend 50-60% equity allocations for mid-60s retirees versus 35% ...

In a trial, ERAS for ambulatory TURBT showed promise for improving early recovery compared with usual care. In a trial, quality of recovery was significantly better for patients receiving an enhanced ...